Abstract
COVID-19 is a respiratory tract infection that can range from being mild to fatal. In India, the countrywide lockdown has been imposed since 24th march, 2020, and has got multiple extensions with different guidelines for each phase. Among various models of epidemiology, we use the SIR(D) model to analyze the extent to which this multi-phased lockdown has been active in ‘flattening the curve’ and lower the threat. Analyzing the effect of lockdown on the infection may give us a better insight into the evolution of epidemic while implementing the quarantine procedures as well as improving the healthcare facilities. For accurate modelling, incorporating various parameters along with sophisticated computational facilities, are required. Parallel to SIRD modelling, we tend to compare it with the Ising model and derive a quantum circuit that incorporates the rate of infection and rate of recovery, etc as its parameters. The probabilistic plots obtained from the circuit qualitatively resemble the shape of the curve for the spread of Coronavirus. We also demonstrate how the curve flattens when the lockdown is imposed. This kind of quantum computational approach can be useful in reducing space and time complexities of a huge amount of information related to the epidemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding has been used for this analysis.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
It is a mathematical modelling analysis, hence no ethics committee approval was needed
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All the data have been imported from COVID-19 India Tracker, it is a crowd-sourced database.